1. Pirfenidone is a Renal Protective Drug: Mechanisms, Signalling Pathways, and Preclinical Evidence;Bai,2021
2. Effect of pirfenidone on vascular proliferation, inflammation and fibrosis in an abdominal adhesion rat model;Hasdemir;J. Investig. Surg.,2017
3. Medicine M. PPARγ/NF-κB and TGF-β1/Smad Pathway are Involved in the Anti-fibrotic Effects of Levo-tetrahydropalmatine on Liver Fibrosis;Yu,2021
4. A Review of Pirfenidone as an Anti-Fibrotic in Idiopathic Pulmonary Fibrosis and Its Probable Role in Other Diseases;Shah,2021
5. Discovery D. From Dissection of Fibrotic Pathways to Assessment of Drug Interactions to Reduce Cardiac Fibrosis and Heart Failure;Garoffolo,2021